Conjugates With Inhibitory Receptor Ligands to Induce Anergy in Insulin-Binding B Cells
Copyright © Targeted News Service 2024
2024-11-26
ALEXANDRIA, Virginia, Nov. 26 -- UNIVERSITY OF KANSAS, Lawrence, Kansas has been assigned a patent (No. US 12150974 B2, initially filed Jan. 27, 2022) developed by three inventors Kyle Apley, Olathe, Kansas; Mark Farrell, Lawrence, Kansas; and Cory Berkland, Lawrence, Kansas, for "Conjugates with inhibitory receptor ligands to induce anergy in insulin-binding B cells." . . .